BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37217070)

  • 21. Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells.
    Sun H; Wang H; Wang X; Aoki Y; Wang X; Yang Y; Cheng X; Wang Z; Wang X
    Theranostics; 2020; 10(15):6928-6945. PubMed ID: 32550913
    [No Abstract]   [Full Text] [Related]  

  • 22. NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer.
    Chang H; Li B; Zhang X; Meng X
    Biochem Biophys Res Commun; 2020 Feb; 522(2):292-299. PubMed ID: 31761329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
    Sun Z; Gao S; Xuan L; Liu X
    J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of the LncRNA RNF157-AS1 on epithelial ovarian cancer cells through suppression of DIRAS3- and ULK1-mediated autophagy.
    Xu P; Xu S; Pan H; Dai C; Xu Y; Wang L; Cong Y; Zhang H; Cao J; Ge L; Jia X
    Cell Death Dis; 2023 Feb; 14(2):140. PubMed ID: 36805591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.
    Ding YH; Zhou ZW; Ha CF; Zhang XY; Pan ST; He ZX; Edelman JL; Wang D; Yang YX; Zhang X; Duan W; Yang T; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():425-64. PubMed ID: 25624750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA X-inactive-specific transcript contributes to cisplatin resistance in gastric cancer by sponging miR-let-7b.
    Han X; Zhang HB; Li XD; Wang ZA
    Anticancer Drugs; 2020 Nov; 31(10):1018-1025. PubMed ID: 33009035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A feedback loop between GATA2-AS1 and GATA2 promotes colorectal cancer cell proliferation, invasion, epithelial-mesenchymal transition and stemness via recruiting DDX3X.
    Pan Y; Zhu Y; Zhang J; Jin L; Cao P
    J Transl Med; 2022 Jun; 20(1):287. PubMed ID: 35752837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
    Zhu X; Shen H; Yin X; Long L; Chen X; Feng F; Liu Y; Zhao P; Xu Y; Li M; Xu W; Li Y
    Oncotarget; 2017 Jun; 8(24):39154-39166. PubMed ID: 28388577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of lncRNA ASMTL-AS1 in Epithelial Ovarian Cancer Correlates with Worse Prognosis and Cancer Progression.
    Xu H; Tang Y; Liu L; Yan J; Qin L
    Horm Metab Res; 2022 Jul; 54(7):481-488. PubMed ID: 35835145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MSC-AS1 induced cell growth and inflammatory mediators secretion through sponging miR-142-5p/DDX5 in gastric carcinoma.
    Liu Y; Li L; Wu X; Qi H; Gao Y; Li Y; Chen D
    Aging (Albany NY); 2021 Apr; 13(7):10387-10395. PubMed ID: 33819916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
    Zhao J; Liu HR
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells.
    Yang N; Wang C; Wang Z; Zona S; Lin SX; Wang X; Yan M; Zheng FM; Li SS; Xu B; Bella L; Yong JS; Lam EW; Liu Q
    Oncogene; 2017 Jun; 36(24):3428-3440. PubMed ID: 28114286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA TMEM147-AS1 serves as a microRNA-326 sponge to aggravate the malignancy of gastric cancer by upregulating SMAD5.
    Qin X; Jiang Z; Zhu Y; Xue H; Wei C
    Oncol Res; 2021; 29(4):263-273. PubMed ID: 37303938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-874-3p mitigates cisplatin resistance through modulating NF-κB/inhibitor of apoptosis protein signaling pathway in epithelial ovarian cancer cells.
    Wang Y; Yan C; Qi J; Liu C; Yu J; Wang H
    Mol Cell Biochem; 2022 Jan; 477(1):307-317. PubMed ID: 34716858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E2F1-regulated long non-coding RNA RAD51-AS1 promotes cell cycle progression, inhibits apoptosis and predicts poor prognosis in epithelial ovarian cancer.
    Zhang X; Liu G; Qiu J; Zhang N; Ding J; Hua K
    Sci Rep; 2017 Jun; 7(1):4469. PubMed ID: 28667302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis.
    Miao JT; Gao JH; Chen YQ; Chen H; Meng HY; Lou G
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31189742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA ACTA2-AS1 inhibits the cisplatin resistance of non-small cell lung cancer cells through inhibiting autophagy by suppressing TSC2.
    Liu X; Zhang X; Du S
    Cell Cycle; 2022 Feb; 21(4):368-378. PubMed ID: 34985374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
    Zhang WY; Liu YJ; He Y; Chen P
    J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of long noncoding RNA HMMR-AS1 in epithelial ovarian cancer: an independent prognostic factor.
    Chu ZP; Dai J; Jia LG; Li J; Zhang Y; Zhang ZY; Yan P
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8145-8150. PubMed ID: 30556852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cells.
    Ranzuglia V; Lorenzon I; Pellarin I; Sonego M; Dall'Acqua A; D'Andrea S; Lovisa S; Segatto I; Coan M; Polesel J; Serraino D; Sabatelli P; Spessotto P; Belletti B; Baldassarre G; Schiappacassi M
    Oncogene; 2020 Oct; 39(40):6370-6386. PubMed ID: 32848212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.